Related Experiment Video

Updated: May 22, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Predictive Bcl-2 family binding models rooted in experiment or structure

Joe DeBartolo1, Sanjib Dutta, Lothar Reich

  • 1Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Journal of Molecular Biology
|May 24, 2012
PubMed

Insights

Researchers explored Bcl-2 family protein interactions to understand cancer development. They developed models to predict binding specificity, aiding in the design of new cancer therapeutics and diagnostics.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Biochemistry

Background:

  • Proteins of the Bcl-2 family regulate programmed cell death and are crucial in cancer and chemotherapy resistance.
  • BH3-only proteins initiate cell death by binding to pro-survival Bcl-2 receptors, presenting a molecular recognition challenge due to conserved structures.
  • Understanding Bcl-2 interaction specificity is vital for developing peptide-based cancer therapeutics and diagnostics.

Purpose of the Study:

  • To expand the experimentally tested BH3 sequence space for interactions with five human anti-apoptotic receptors.
  • To identify key protein features determining Bcl-2 family interaction specificity.
  • To develop predictive models for Bcl-2 affinity and specificity.

Main Methods:

  • Utilized peptide SPOT arrays and deep sequencing from yeast display screening to gather interaction data.
  • Constructed two data-based models for predicting affinity and specificity.
  • Developed a novel structure-based statistical potential, STATIUM, for predicting Bcl-2 interactions.

Main Results:

  • Generated extensive data on BH3 sequence space interactions with anti-apoptotic Bcl-2 receptors.
  • The STATIUM model demonstrated remarkable accuracy in predicting Bcl-2 affinity and specificity without experimental training.
  • Compared the performance of data-based and structure-based models, including STATIUM.

Conclusions:

  • The study provides significant insights into the determinants of Bcl-2 family specificity.
  • The developed models, particularly STATIUM, show promise in guiding the prediction and design of novel Bcl-2 family interactions.
  • These findings can accelerate the development of targeted cancer therapeutics and diagnostics.

More Related Videos

Single-Molecule Measurement of Protein Interaction Dynamics Within Biomolecular Condensates06:48

Single-Molecule Measurement of Protein Interaction Dynamics Within Biomolecular Condensates

Published on: January 5, 2024

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...